Difference between revisions of "Analgesics"

From Practice Parameters
Jump to navigation Jump to search
(Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.02 ANALGESICS=== ====Morphine Sulfate / Analgesic==== '''DESCRIPTION''' * It is a potent analgesic that also causes some vasodilata...")
 
m (Protected "Analgesics" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(No difference)

Revision as of 09:15, 10 February 2018

Section 8 - MEDICATION GUIDELINES

8.02 ANALGESICS

Morphine Sulfate / Analgesic

DESCRIPTION

  • It is a potent analgesic that also causes some vasodilatation. It reduces myocardial oxygen demand.

INDICATIONS

CONTRAINDICATIONS

  • Significant hypotension, COPD, or hypersensitivity to the medication.

PRECAUTIONS

  • It may cause respiratory depression. Naloxone should be readily available to counteract

the effects of Morphine Sulfate. DOSAGE

  • Refer to appropriate PRACTICE PARAMETER for specific dosages.
  • Pediatrics: 0.1 mg/kg, refer to Handtevy System for specific dosages


Nitrous Oxide (NITRONOX) / Analgesic

DESCRIPTION

  • It is a relatively weak anesthetic agent with both sedative and analgesic properties.

INDICATIONS

CONTRAINDICATIONS

  • Head injuries, chest injuries, COPD< pulmonary edema, pregnant patients under 20 weeks gestation, suspected bowel obstruction, decompression syndrome, and shock regardless of cause.
  • May cause drowsiness, dizziness, respiratory depression, or arrest, nausea, vomiting, or euphoria. Pregnant EMS care providers, under 20 weeks gestation, should not be in the presence of NITROUS OXIDE due to the fact that it is an inert gas.

DOSAGE

  • Self-administered 50% Oxygen and 50 % Nitrous mixture.